![]() | |
Clinical data | |
---|---|
Other names | Δ7-Estrone; 7-Dehydroestrone; Estra-1,3,5(10),7-tetraen-3-ol-17-one |
Routes of administration | By mouth |
Drug class | Estrogen |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.006.809 |
Chemical and physical data | |
Formula | C18H20O2 |
Molar mass | 268.356 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Equilin is a naturally occurring estrogen sex hormone found in horses as well as a medication. [1] [2] [3] It is one of the estrogens present in the estrogen combination drug preparations known as conjugated estrogens (CEEs; e.g. Premarin) and esterified estrogens (EEs; e.g. Estratab, Menest). [2] [3] CEEs is the most commonly used form of estrogen medications in hormone replacement therapy (HRT) for menopausal symptoms in the United States. [3] Estrone sulfate is the major estrogen in CEEs (about 50%) while equilin sulfate is the second major estrogen in the formulation, present as about 25% of the total. [2] [3]
Equilin is an estrogen, or an agonist of the estrogen receptors (ERs), the ERα and ERβ. [2] In terms of relative binding affinity for the ERs, equilin has about 13% and 49% of that of estradiol for the ERα and ERβ, respectively. [2] Analogously to the reversible transformation of estrone into estradiol by 17β-hydroxysteroid dehydrogenase, equilin can be converted into the more potent estrogen 17β-dihydroequilin in the body. [2] [3] This estrogen has about 113% and 108% of the relative binding affinities of estradiol for the ERα and ERβ, respectively. [2] [3] Equilin is present in CEEs in the form of equilin sulfate, which itself is inactive and acts as a prodrug of equilin via steroid sulfatase. [2] [3]
Similarly to synthetic estrogens like ethinylestradiol, equilin and CEEs have disproportionate effects in certain tissues such as the liver and uterus relative to bioidentical human estrogens like estradiol and estrone. [2] Because of their disproportionate potency in the liver, equilin and CEEs have relatively increased effects on liver protein synthesis compared to estradiol. [2]
A dosage of 0.25 mg/day equilin sulfate is equivalent to 0.625 mg/day CEEs in terms of relief from hot flashes. [2] At a dosage of 0.625 mg/day equilin sulfate, the increases in circulating levels of sex hormone-binding globulin (SHBG), corticosteroid-binding globulin, and angiotensinogen were 1.5 to 8 times those observed with estrone sulfate. [2] Equilin has about 42% of the relative potency of CEEs in the vagina and 80% of the relative potency of CEEs in the uterus, while its more active form, 17β-dihydroequilin, has about 83% of the relative potency of CEEs in the vagina and 200% of the relative potency of CEEs in the uterus. [2]
Estrogen | HF | VE | UCa | FSH | LH | HDL - C | SHBG | CBG | AGT | Liver |
---|---|---|---|---|---|---|---|---|---|---|
Estradiol | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
Estrone | ? | ? | ? | 0.3 | 0.3 | ? | ? | ? | ? | ? |
Estriol | 0.3 | 0.3 | 0.1 | 0.3 | 0.3 | 0.2 | ? | ? | ? | 0.67 |
Estrone sulfate | ? | 0.9 | 0.9 | 0.8–0.9 | 0.9 | 0.5 | 0.9 | 0.5–0.7 | 1.4–1.5 | 0.56–1.7 |
Conjugated estrogens | 1.2 | 1.5 | 2.0 | 1.1–1.3 | 1.0 | 1.5 | 3.0–3.2 | 1.3–1.5 | 5.0 | 1.3–4.5 |
Equilin sulfate | ? | ? | 1.0 | ? | ? | 6.0 | 7.5 | 6.0 | 7.5 | ? |
Ethinylestradiol | 120 | 150 | 400 | 60–150 | 100 | 400 | 500–600 | 500–600 | 350 | 2.9–5.0 |
Diethylstilbestrol | ? | ? | ? | 2.9–3.4 | ? | ? | 26–28 | 25–37 | 20 | 5.7–7.5 |
Sources and footnotes
Notes: Values are ratios, with estradiol as standard (i.e., 1.0). Abbreviations:
HF = Clinical relief of
hot flashes.
VE = Increased
proliferation of
vaginal epithelium.
UCa = Decrease in
UCa .
FSH = Suppression of
FSH levels.
LH = Suppression of
LH levels.
HDL-
C,
SHBG,
CBG, and
AGT = Increase in the serum levels of these
liver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (hot flashes/
gonadotropins). Sources: See template. |
Equilin has about 8% of the relative binding affinity of testosterone for SHBG, relative to 12% in the case of estrone. [2] In terms of plasma protein binding, it is bound 26% to SHBG and 13% to albumin. [2] The metabolic clearance rates of equilin and equilin sulfate are 2,640 L/day/m2 and 175 L/day/m2, respectively. [2] In accordance, the biological half-life of equilin sulfate is substantially longer than that of equilin. [2] Equilin is converted into 17β-dihydroequilin in the liver and in other tissues. [2] [3] Equilin and 17β-dihydroequilin can also be transformed into equilenin and 17β-dihydroequilenin. [2] [3] Equilin is excreted in the form of glucuronide conjugates. [2]
Equilin, also known as δ7-estrone or as 7-dehydroestrone, as well as estra-1,3,5(10),7-tetraen-3-ol-17-one, is a naturally occurring estrane steroid and an analogue of estrone. [2] [3] In terms of chemical structure and pharmacology, equilin is to 17β-dihydroequilin (δ7-17β-estradiol) as estrone is to estradiol. [2] [3]
![]() | |
Clinical data | |
---|---|
Other names | Δ7-Estrone; 7-Dehydroestrone; Estra-1,3,5(10),7-tetraen-3-ol-17-one |
Routes of administration | By mouth |
Drug class | Estrogen |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.006.809 |
Chemical and physical data | |
Formula | C18H20O2 |
Molar mass | 268.356 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(verify) |
Equilin is a naturally occurring estrogen sex hormone found in horses as well as a medication. [1] [2] [3] It is one of the estrogens present in the estrogen combination drug preparations known as conjugated estrogens (CEEs; e.g. Premarin) and esterified estrogens (EEs; e.g. Estratab, Menest). [2] [3] CEEs is the most commonly used form of estrogen medications in hormone replacement therapy (HRT) for menopausal symptoms in the United States. [3] Estrone sulfate is the major estrogen in CEEs (about 50%) while equilin sulfate is the second major estrogen in the formulation, present as about 25% of the total. [2] [3]
Equilin is an estrogen, or an agonist of the estrogen receptors (ERs), the ERα and ERβ. [2] In terms of relative binding affinity for the ERs, equilin has about 13% and 49% of that of estradiol for the ERα and ERβ, respectively. [2] Analogously to the reversible transformation of estrone into estradiol by 17β-hydroxysteroid dehydrogenase, equilin can be converted into the more potent estrogen 17β-dihydroequilin in the body. [2] [3] This estrogen has about 113% and 108% of the relative binding affinities of estradiol for the ERα and ERβ, respectively. [2] [3] Equilin is present in CEEs in the form of equilin sulfate, which itself is inactive and acts as a prodrug of equilin via steroid sulfatase. [2] [3]
Similarly to synthetic estrogens like ethinylestradiol, equilin and CEEs have disproportionate effects in certain tissues such as the liver and uterus relative to bioidentical human estrogens like estradiol and estrone. [2] Because of their disproportionate potency in the liver, equilin and CEEs have relatively increased effects on liver protein synthesis compared to estradiol. [2]
A dosage of 0.25 mg/day equilin sulfate is equivalent to 0.625 mg/day CEEs in terms of relief from hot flashes. [2] At a dosage of 0.625 mg/day equilin sulfate, the increases in circulating levels of sex hormone-binding globulin (SHBG), corticosteroid-binding globulin, and angiotensinogen were 1.5 to 8 times those observed with estrone sulfate. [2] Equilin has about 42% of the relative potency of CEEs in the vagina and 80% of the relative potency of CEEs in the uterus, while its more active form, 17β-dihydroequilin, has about 83% of the relative potency of CEEs in the vagina and 200% of the relative potency of CEEs in the uterus. [2]
Estrogen | HF | VE | UCa | FSH | LH | HDL - C | SHBG | CBG | AGT | Liver |
---|---|---|---|---|---|---|---|---|---|---|
Estradiol | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
Estrone | ? | ? | ? | 0.3 | 0.3 | ? | ? | ? | ? | ? |
Estriol | 0.3 | 0.3 | 0.1 | 0.3 | 0.3 | 0.2 | ? | ? | ? | 0.67 |
Estrone sulfate | ? | 0.9 | 0.9 | 0.8–0.9 | 0.9 | 0.5 | 0.9 | 0.5–0.7 | 1.4–1.5 | 0.56–1.7 |
Conjugated estrogens | 1.2 | 1.5 | 2.0 | 1.1–1.3 | 1.0 | 1.5 | 3.0–3.2 | 1.3–1.5 | 5.0 | 1.3–4.5 |
Equilin sulfate | ? | ? | 1.0 | ? | ? | 6.0 | 7.5 | 6.0 | 7.5 | ? |
Ethinylestradiol | 120 | 150 | 400 | 60–150 | 100 | 400 | 500–600 | 500–600 | 350 | 2.9–5.0 |
Diethylstilbestrol | ? | ? | ? | 2.9–3.4 | ? | ? | 26–28 | 25–37 | 20 | 5.7–7.5 |
Sources and footnotes
Notes: Values are ratios, with estradiol as standard (i.e., 1.0). Abbreviations:
HF = Clinical relief of
hot flashes.
VE = Increased
proliferation of
vaginal epithelium.
UCa = Decrease in
UCa .
FSH = Suppression of
FSH levels.
LH = Suppression of
LH levels.
HDL-
C,
SHBG,
CBG, and
AGT = Increase in the serum levels of these
liver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (hot flashes/
gonadotropins). Sources: See template. |
Equilin has about 8% of the relative binding affinity of testosterone for SHBG, relative to 12% in the case of estrone. [2] In terms of plasma protein binding, it is bound 26% to SHBG and 13% to albumin. [2] The metabolic clearance rates of equilin and equilin sulfate are 2,640 L/day/m2 and 175 L/day/m2, respectively. [2] In accordance, the biological half-life of equilin sulfate is substantially longer than that of equilin. [2] Equilin is converted into 17β-dihydroequilin in the liver and in other tissues. [2] [3] Equilin and 17β-dihydroequilin can also be transformed into equilenin and 17β-dihydroequilenin. [2] [3] Equilin is excreted in the form of glucuronide conjugates. [2]
Equilin, also known as δ7-estrone or as 7-dehydroestrone, as well as estra-1,3,5(10),7-tetraen-3-ol-17-one, is a naturally occurring estrane steroid and an analogue of estrone. [2] [3] In terms of chemical structure and pharmacology, equilin is to 17β-dihydroequilin (δ7-17β-estradiol) as estrone is to estradiol. [2] [3]